Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials

Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials

In the era of personalized medicine there is an increasing need for the assessment of patient-reported outcomes (PROs) to become a standard of patient care. Patient-reported outcome measures (PROM) are important in assessing significant and meaningful changes as a result of an intervention based on...

Full description

Bibliographic Details
Main Authors: Edward Laane, Sam Salek, Esther Natalie Oliva, Christine Bennink, Solène Clavreul, Paul G Richardson, Christof Scheid, Katja Weisel, Tatyana Ionova
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Cancers
Subjects:
multiple myeloma
patient-reported outcomes
quality of life
symptoms
systematic review
clinical trials
Online Access:https://www.mdpi.com/2072-6694/15/24/5764

Internet

https://www.mdpi.com/2072-6694/15/24/5764

Similar Items